Evaluation the effect of Fractional Erbium glass 1540 Laser on treatment of macular amyloidosis

Mashhad University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新: 2018年3月26日

试验速览

暂无简介。

•Clinically confirmed macular amyloidosis
•macular amyloidosis lesions should be on upper back area
•o current skin diseases like active dermatitis, active acne, hypertrophic scars or keloids
•patients with Fitzpatrick skin types 2 to 4
•written informed consent from patients for participation in the study and digital imaging from lesions
•no use of Isotretinoin during the last 3 month
•having no heart pacemaker
•no record of sensitivity to lidocaine

•unreal expectations from treatment results
•macular amyloidosis lesions not being on upper back areas
•intolerance against laser treatment
•pregnancy during treatment
•unwillingness of patient to continue participating in the study or digital imaging from lesions
•Coagulopathy
•Patients who were under topical treatment one month before study
•existence of hypertrophic scars or keloids
•Treatment with systemic retinoid during the last 6 month
•other dermatologic diseases like skin infections and active lesions in the treatment area

发起方